Assignment

Assignment

Theme

Vaccines for malaria

Objective

The purpose of this study is to expand the boundaries of our knowledge by exploring some relevant facts and figures related to the contributions of Manuel Elkin Pataroyo in developing Vaccines for malaria

Activity

In this paper, we will examine the history of vaccine development for Malaria. Afterwards, we will analyze the work of Manuel Elkin Pataroyo in the field of Vaccine development for Malaria. Finally, we will examine the benefits of vaccine for eradicating Malaria.

Scientist Background

Manuel Elkin Pataroyo is a Colombian pathologist recognized worldwide for developing a synthetic vaccine (SPf66) against malaria, a disease common in tropical areas, transmitted by the mosquito Anopheles gambiae and annually kills one million children and causes more 500 million clinical cases (Graves, 2009).

Scientist Contribution

Vaccines for malaria are being developed, but effective vaccines are not yet fully available. The vaccine is an artificial product, which after the administration, prevents the appearance and development of specific diseases.In a nutshell, the vaccine is a preparation based on micro-organisms, which is harmful in more or less relaxed. This is achieved by chemical or physical process by which weakens or even kills germs. Malaria is currently a major parasitic disease in the world and it produces approximately one million deaths annually (Susan, 1998).

In 1967, the first research was performed in order to analyze the potential of malaria vaccine. It was done by immunizing mice with sporozoites in live, attenuated radiation, protecting about 60% of mice after a further injection of sporozoites normal, viable. Since the seventies there have been major efforts to develop similar vaccination strategies in humans. It was found that a person can be protected against infection by P.'' hook'' if they receive more than 1,000 bites from infected mosquitoes, were irradiated (Holloway, 1996).

The first vaccine developed that has passed field is SPf66, developed ...